Final-Program-ATS-2023-AP.vp

324

WEDNESDAY • MAY 24

202 Sleep-related Hypoxemia in COPD Patients Is Associated With Sarcopenia: An Analysis of the Cleveland Clinic Sleep Registry/ A. Attaway, Cleveland, OH 203 Impact of Objective Positive Airway Pressure Adherence on Healthcare Resource Utilization and Costs Among Individuals With Comorbid Obstructive Sleep Apnea and Depression: A National Analysis/ E.M. Wickwire, Baltimore, MD 204 Predictors of 90-day Adherence to Positive Airway Pressure Therapy Among a National Sample of Individuals With Comorbid Depression and Obstructive Sleep Apnea/ E.M. Wickwire, Baltimore, MD 205 Sex Differences in Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease Overlap Syndrome/ M.M. Lowery, Gainesville, FL 206 Dose-dependent Effects of Positive Airway Pressure Therapy on Daytime Sleepiness and Blood Pressure in Type 2 Diabetes and Obstructive Sleep Apnea/ R.N. Aurora, New York, NY 207 Performance of Claims-Based Algorithms for Adherence to Positive Airway Pressure Therapy in Commercially Insured Patients With Obstructive Sleep Apnea/ N. Alpert, San Diego, CA 208 Associations Between Sleep Apnea and Acute COVID-19 Infection Severity Are Sex- and Date-specific/ B.E. Cade, Boston, MA 209 Longitudinal Maternal Sleep Position Patterns and Fetal Growth Velocity in Women With Overweight or Obesity/ J. Katz, Providence, RI 210 The Long-term Impacts of the COVID-19 Pandemic on Obstructive Sleep Apnea (OSA)-related Healthcare/ T. Kendzerska, Ottawa, Canada 211 Incident OSA Increases Repolarization Heterogeneity During Sleep/ A.L. Koch, Miami, FL 212 Sleep Quality as a Novel Mediator of Reductions in Daytime Breathlessness With Low-dose Morphine in People With Chronic Obstructive Pulmonary Disease/ D.J. Eckert, Bedford Park, Australia 213 Diagnosis and Management of Patients Hospitalized With Acute-on-Chronic Hypercapnic Respiratory Failure Due to Obesity Hypoventilation Syndrome/ J.M. Neborak, Chicago, IL 214 Prevalence of Sleep Apnoea in Patients With Type 1 Diabetes and Its Association With Comorbidities and Diabetic Complications: A French Nationwide Prospective Study/ J.-L. Pépin, Grenoble Cedex 9, France 215 Daytime Sleepiness and Subclinical Atherosclerosis in OSA/ J.M. Marin, Zaragoza, Spain

616 Clinical and Radiographic Predictors of Mortality or Transplant in Patients With Idiopathic Pulmonary Fibrosis/ S. Macisaac, Hamilton, Canada 617 The Addition of Imaging Improves Mortality Prediction in IPF/ K.R. Kirov, Cambridge, United Kingdom 618 Automated Image Analysis of Vascular and Fibrotic Lung Volumes Shows Association With IPF Mortality/ K.R. Kirov, Cambridge, United Kingdom 619 Microscopic Validation of Deep Learning Based Texture Classification of Idiopathic Pulmonary Fibrosis Patterns Visible on Thoracic Computed Tomography/ D.M. Vasilescu, Vancouver, Canada 620 Patient Specific Metrics of Tracheal Deformation, Predicted Toxicant Uptake and Histopathology in IPF/ S. Royce, Clayton, Australia 621 Inhibition of Poly (ADP-Ribose) Polymerase Attenuates Bleomycin-Induced Pulmonary Fibrosis in a Sheep Model/ H.B. Derseh, Berwick, Australia 622 Multifunctional Liposomes to Improve Pulmonary Administration of Antifibrotic Drugs/ M. Piñol, Madrid, Spain 623 Brilaroxazine Efficacy in a Bleomycin-induced Rodent Model of Idiopathic Pulmonary Fibrosis/ L. Bhat, Cupertino, CA 624 Magnetoliposomes for Monitoring Pulmonary Administration of Antifibrotic Drugs/ L. Fernández Méndez, Leioa, Spain

BEHAVIORAL • CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION

D30

INTEGRATING OSA AND COMORBIDITIES FOR EFFECTIVE THERAPIES

8:00 a.m. - 10:00 a.m.

Walter E. Washington Convention Center Room 103 A-B (Street Level)

Poster Viewing

8:00-8:45 8:45-10:00

Discussion

Chairing: H. Schotland, MD, ATSF, New York, NY

S.R. Pendharkar, MD, MSc, ATSF, Calgary, Canada B.J. Yee, MBChB, PhD, Sydney, Australia

B. Selim, MD, Rochester, MN M. Macrea, MD, Salem, VA 201 Test Performance of Serum Bicarbonate in Identifying Hypercapnia Across Settings and Diseases/ B.W. Locke, Salt Lake City, UT

ATS 2023 • Washington, DC